Vascular Mechanism of Action of Endothelin‐1: Effect of Ca2+ Antagonists
Vascular Mechanism of Action of Endothelin‐1: Effect of Ca2+ Antagonists
复制标题
内皮素-1 作用的血管机制:Ca2+ 拮抗剂的作用
DOI:
--
复制
发表时间:
1989
影响因子:
3
通讯作者:
P. Braquet
中科院分区:
文献类型:
--
作者:
Pierre étienne Chabrier;M. Auguet;P. Roubert;M. Lonchampt;V. Gillard;J. Guillon;S. Delaflotte;P. Braquet
Summary The vasoconstrictive properties of the endothelium-derived peptide, endothelin-1 (ET-1), were investigated on rat isolated aorta and on cultured rat aortic smooth muscle cells. In rat isolated aorta, endothelin-1 induced a slow and sustained contraction in a Ca2+-free medium; after calcium readmission, an additional sustained contraction was elicited. In vascular smooth muscle cells, endothelin-1 provoked a dose-dependent Ca2+ influx that was not inhibited by calcium entry blockers (nifedipine, D 600, or diltiazem). In these cells, [125I]-endothelin-l bound to a specific, saturable, and high affinity recognition site (Kd about 10–9 M and Bmax = 52 $$ 2 fmol/106 cells). The binding was not reversible and not affected by calcium antagonists. These data do not support the hypothesis that endothelin-1 acts as an endogenous agonist of the voltage-dependent Ca2+ channels. The action of endothelin-1 can be separated into two components: one dependent on Ca2+ influx but insensitive to calcium antagonists and another independent of extracellular Ca2+. The irreversible binding of endothelin-1 may reflect an internalization of the ligand inside the cell membrane, leading to multiple contractile events.